readthroughSign in
CompanyTPSTNasdaqBrisbane, CA

Tempest Therapeutics

Tempest develops in vivo CAR-T therapies for cancer and autoimmune disease.

8-KNov 16Latest SEC filing
Nov 13Latest story

November 2026

October 2026

September 2026

August 2026

July 2026